ADIAL PHARMACEUTICALS, INC. - FORM S-1/A - EX-23.1 - CONSENT OF FRIEDMAN LLP - November 22, 2017

Attached files

file filename
EX-4.17 - FORM OF COMMON STOCK PURCHASE WARRANT DATED NOVEMBER 20, 2017 BY AND AMONG ADIAL - ADIAL PHARMACEUTICALS, INC.fs12017a3_ex4-17adialpharma.htm
S-1/A - AMENDMENT NO. 3 TO FORM S-1 - ADIAL PHARMACEUTICALS, INC.fs12017a3_adialpharma.htm
EX-10.22 - FORM OF SECURITY AGREEMENT - ADIAL PHARMACEUTICALS, INC.fs12017a3_ex10-22adialpharma.htm
EX-10.21 - SECURITIES PURCHASE AGREEMENT DATED AS OF NOVEMBER 20, 2017 BY AND AMONG ADIAL P - ADIAL PHARMACEUTICALS, INC.fs12017a3_ex10-21adialpharma.htm
EX-5.1 - OPINION OF GRACIN & MARLOW, LLP - ADIAL PHARMACEUTICALS, INC.fs12017a3ex5-1_adialpharma.htm
EX-4.16 - FORM OF SECURED PROMISSORY NOTES DATED AS OF NOVEMBER 21, 2017 BY AND BETWEEN AD - ADIAL PHARMACEUTICALS, INC.fs12017a3_ex4-16adialpharma.htm
EX-4.15 - AMENDMENT NO. 2 TO SENIOR SECURED PROMISSORY NOTE DATED AS OF NOVEMBER 21, 2017 - ADIAL PHARMACEUTICALS, INC.fs12017a3_ex4-15adialpharma.htm
EX-4.2 - FORM OF REPRESENTATIVE'S WARRANT AGREEMENT - ADIAL PHARMACEUTICALS, INC.fs12017a3_ex4-2adialpharma.htm
EX-1.1 - FORM OF UNDERWRITING AGREEMENT - ADIAL PHARMACEUTICALS, INC.fs12017a3_ex1-1adialpharma.htm

Exhibit 23.1

 

 

 

 

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

 

We hereby consent to the inclusion in this Amendment No. 3 to the Registration Statement on Form S-1 (File No. 333-220368) of our report dated May 11, 2017, which includes an explanatory paragraph as to the company’s ability to continue as going concern, with respect to the financial statements of ADial Pharmaceuticals, L.L.C. as of December 31, 2016 and 2015 and for the years then ended. We also consent to the reference to our firm under the heading “Experts” in such Registration Statement.

 

/s/ Friedman LLP

 

East Hanover, New Jersey

November 22, 2017

 

 

 

ADIAL PHARMACEUTICALS, INC. Reports